We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca, Pozen Win FDA Approval of NSAID Vimovo
AstraZeneca, Pozen Win FDA Approval of NSAID Vimovo
May 3, 2010
The FDA has approved AstraZeneca and Pozen’s pain-relieving non-steroidal anti-inflammatory drug (NSAID) Vimovo.